By Theresa Gaffney ADOBEPeople with autoimmune disorders don’t usually get to talk about a cure. There’s symptom management, hopeful periods of remission often followed by relapses, but rarely a lasting fix for the way their immune system attacks healthy cells. If the immune system is an army, then those with conditions like lupus, multiple sclerosis, or...
By Paul McClure Radioactive fructose illuminated cancer cells and brain and heart inflammation on a PET scanKirby et al./Journal of Nuclear Medicine A radioactive form of fructose, a natural sugar found in fruit, given to mice lit up areas of cancer and inflammation on a diagnostic medical scan. The researchers say the approach makes diseases easier...
by Hokkaido University Compared with untreated cancer, the TRED-I system significantly reduced cancer size in mice models. Credit: Proceedings of the National Academy of Sciences (2024). DOI: 10.1073/pnas.2310821121A new technology to increase visibility of cancer cells to the immune system using CRISPR has been developed, and could lead to a new way to treat cancer. Major...
by Katherine Egan Bennett, University of Texas at Arlington Credit: Cell Reports (2023). DOI: 10.1016/j.celrep.2023.113516A multi-institutional study co-authored by University of Texas at Arlington scientists uncovered a mechanism by which cancer cells prevent the immune system from activating and attacking the cancerous invaders. The study, published in Cell Reports, sheds light on why immunotherapy treatments don’t...
In a new study, researchers report that health professionals who lost weight without starting a diet or exercise plan within the previous two years had a significantly higher risk of developing cancer within the following year.Upper gastrointestinal tract, hematologic, colorectal, and lung cancers were more common in people with rapid unexpected weight loss.Experts say people...
by Impact Journals LLC Validation of expression of the LTBR gene. Credit: Aging (2024). DOI: 10.18632/aging.205356A new research paper titled “Systematic analysis of the prognostic value and immunological function of LTBR in human cancer” has been published in Aging. Lymphotoxin beta receptor (LTBR) is a positive T cell proliferation regulator gene. It is closely associated...
by Tanner Stening, Northeastern University Mansoor Amiji, University Distinguished Professor in the Departments of Pharmaceutical Sciences and Chemical Engineering at Northeastern. Credit: Matthew Modoono/Northeastern UniversityOne of the great promises in the field of cancer immunotherapy is the emergence of cancer vaccines. Unlike traditional vaccines that are tailored to infectious diseases, cancer vaccines work by teaching the...
“THE PATIENTS ARE GETTING YOUNGER.”CANCERPeople below the age of 50 are getting cancer more than ever before — and doctors are stumped as to why. As the Wall Street Journal reports, the shocking 2020 death of beloved actor Chadwick Boseman, who died of colorectal cancer at only 43 years old, seemed to wake the public...
by Katie Neith, City of Hope National Medical Center Hope researchers discovered that ILC2s can attack cancer cells. Credit: City of HopeAccording to preclinical research published in Cell researchers at City of Hope have discovered that a type of immune cell in the human body known to be important for allergy and other immune responses can...
by Chris Barncard, University of Wisconsin-Madison Credit: Unsplash/CC0 Public DomainThanks to machine learning algorithms, short pieces of DNA floating in the bloodstream of cancer patients can help doctors diagnose specific types of cancer and choose the most effective treatment for a patient. The new analysis technique, created by University of Wisconsin–Madison researchers and published recently in...
